BNP at discharge in acute heart failure patients: Is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 209-214

  Pimenta, Joana ^a,b   Paulo, Cristiana ^a,b   Mascarenhas, Joana ^a,b   Gomes, André ^a   Azevedo, Ana ^a,b   Rocha Gonçalves, Francisco ^a,b   Bettencourt, Paulo ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

B type natriuretic peptide; Hypervolemia; Predictors

Indexed keywords

ALBUMIN; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; FUROSEMIDE; HEMOGLOBIN; LISINOPRIL; SPIRONOLACTONE;

ACUTE HEART FAILURE; AGED; ARTICLE; BLOOD VOLUME; BODY MASS; CARDIAC PATIENT; CARDIOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INDEX; HEMODYNAMIC PARAMETERS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC DYSFUNCTION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD VOLUME DETERMINATION; BODY FLUIDS; CARDIOGRAPHY, IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE;

EID: 78650035614     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.08.001     Document Type: Article

References (35)

1. V. Cheng, R. Kazanegra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
2. P. Bettencourt, S. Ferreira, A. Azevedo, and A. Ferreira Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure Am J Med 113 2002 215 219
3. D. Logeart, G. Thabut, and P. Jourdain Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 2004 635 641
4. A. Harrison, L.K. Morrison, and P. Krishnaswamy B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann Emerg Med 39 2002 131 138
5. P. Bettencourt, A. Azevedo, J. Pimenta, F. Frioes, S. Ferreira, and A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174
6. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
7. C.M. Balion, P. Santaguida, and R. McKelvie Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP Clin Biochem 41 2008 231 239
8. L.W. Stevenson, and A.S. Maisel Clinical use of natriuretic peptides in the diagnosis and management of heart failure D.A. Morrow, Cardiovascular biomarkers: pathophysiology and disease management 2006 Humana Press Totowa (NJ) 387 408
9. N.M. Albert, M.D. Hail, J. Li, and J.B. Young Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure Am J Crit Care 13 2004 469 479
10. M.H. Drazner, B. Thompson, and P.B. Rosenberg Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy Am J Cardiol 89 2002 993 995
11. European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM) K. Dickstein, and A. Cohen-Solal ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 10 2008 933 989
12. A.S. Levey, T. Greene, J. Kusek, and G. Beck A simplified equation to predict glomerular filtration rate from serum creatinine (abstract) J Am Soc Nephrol 11 2000 155A
13. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. kidney disease outcome quality initiative Am J Kidney Dis 2 Suppl 1 2002 S1 S266
14. C. Lucas, W. Johnson, and M.A. Hamilton Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure Am Heart J 140 2000 824 826
15. M. Gheorghiade, G. Filippatos, L. De Luca, and J. Burnett Congestion in acute heart failure syndromes: an essential target of evaluation and treatment Am J Med 119 12 Suppl 1 2006 S3 S10
16. A.S. Androne, K. Hryniewicz, A. Hudaihed, D. Mancini, J. Lamanca, and S.D. Katz Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes Am J Cardiol 93 10 2004 1254 1259
17. P. Jourdain, G. Jondeau, and F. Funck J Am Coll Cardiol 49 2007 1733 1739
18. M.R. Shah STARBRITE investigators STARBRITE: a randomized pilot trial of BNP-guided therapy in patients with advanced heart failure. (Abstract) Circulation 114 2006 II 548
19. S. Arquès, P. Ambrosi, R. Gélisse, R. Luccioni, and G. Habib Hypoalbuminemia in elderly patients with acute diastolic heart failure J Am Coll Cardiol 42 4 2003 712 716
20. T. Horwich, K. Kalantar-Zadeh, R. MacLellan, and G. Fonarow Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 5 2008 883 889
21. B.R. Don, and G. Kaysen Serum albumin: relationship to inflammation and nutrition Sem Dial 17 2004 432 437
22. M.P. Fuhrman, P. Charney, and C.M. Mueller Hepatic proteins and nutrition assessment J Am Diet Assoc 104 2004 1258 1264
23. G.A. Kaysen, J.A. Dubin, and H.G. Müller Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients Kidney Int 65 2004 1408 1415
24. F. Bursi, S.A. Weston, and M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
25. D.W. Kitzman, W.C. Little, and P.H. Brubaker Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA 288 2002 2144 2150
26. A.S. Maisel, J. McCord, and R.M. Nowak Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study J Am Coll Cardiol 41 2003 2010 2017 (Pubitemid 36677124)
27. Y. Iwanaga, I. Nishi, and S. Furuichi B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J Am Coll Cardiol 47 2006 742 748
28. M. O'Donoghue, A. Chen, A.L. Baggish, S. Anwaruddin, D.G. Krauser, and R. Tung The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail 71 5 Suppl 2005 S9 S14
29. H.H. Chen Heart failure: a state of brain natriuretic deficiency or resistance or both! J Am Coll Cardiol 49 2007 1089 1091
30. M. Nakamura, N. Arakawa, H. Yoshida, S. Makita, H. Niinuma, and K. Hiramori Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure Am Heart J 135 1998 414 420
31. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
32. T.B. Horwich, M.A. Hamilton, and G.C. Fonarow B-type natriuretic peptide levels in obese patients with advanced heart failure J Am Coll Cardiol 47 1 2006 85 90
33. A. Bayes-Genis, D.M. Lloyd-Jones, and R.R. Van Kimmenade Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea Arch Intern Med 167 2007 400 407
34. K.N. Luckenbill, R.H. Christenson, and A.S. Jaffe Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage Clin Chem 54 2008 619 621
35. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150